Cristina Vazquez Guillamet

Medicine & Life Sciences

1. Septic Shock 100%
2. Sepsis 89%
3. Infections 87%
4. Anti-Bacterial Agents 80%
5. Critical Illness 78%
6. Intensive Care Units 72%
7. Ventilator-Associated Pneumonia 67%
8. Lung 65%
9. Mortality 59%
10. Methicillin-Resistant Staphylococcus aureus 55%
11. Transplant Recipients 54%
12. Gram-Negative Bacteria 51%
13. Antimicrobial Stewardship 49%
14. Artificial Respiration 46%
15. Critical Care 37%
16. Pneumonia 34%
17. Acinetobacter 33%
18. Cohort Studies 31%
19. Microbial Drug Resistance 31%
20. Lung Transplantation 29%
21. Decision Making 28%
22. Thorax 28%
23. Healthcare-Associated Pneumonia 28%
24. Hospital Rapid Response Team 27%
25. B7-H1 Antigen 27%
26. Therapeutics 26%
27. Bacteremia 26%
28. Cefepime 25%
29. Coronavirus 25%
30. Clinical Decision Rules 25%
31. Hospital Mortality 24%
32. Skilled Nursing Facilities 24%
33. Candidemia 24%
34. Epidemiology 24%
35. Soft Tissue Infections 23%
36. Odds Ratio 23%
37. Meropenem 23%
38. Tazobactam Drug Combination Piperacillin 22%
39. Terminal Care 22%
40. Gram-Positive Bacteria 22%
41. Pseudomonas 21%
42. Numbers Needed To Treat 21%
43. Confidence Intervals 21%
44. Immunocompromised Host 20%
45. Multiple Drug Resistance 20%
46. Retrospective Studies 19%
47. Bronchoalveolar Lavage 18%
48. Pandemics 18%
49. Vancomycin-Resistant Enterococci 17%
50. Smoke 16%